Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLS

Author:

Theron Paul,Britland Matthew,Holder Donna,Ikeda Yasushi,Rewers Ralph F.,Tiku Ajay

Abstract

AbstractThis position paper is intended to provide recommendations that will help lay the foundation for best practices for medical science liaisons (MSLs) and their activities. Its objective is to outline the roles and responsibilities expected of an MSL and provide clarity on the juxtaposition of MSLs and Sales representatives (SRs) when it comes to scientific exchange versus promotional messaging. It is of utmost importance that industry integrity and ethical standards are assured during external stakeholder engagement as well as medical and scientific communications. This guidance, delivered through the lens of APPA, IFAPP, MAPS and the MSLS executive committees, has been prepared primarily as a supportive resource to assist the Medical Affairs teams in the industry to develop their own set of standard operating procedures (SOPs), codes of conduct and policies within the framework of relevant industry regulations. We acknowledge that whilst there are guidelines already available that provide excellent directive to the MSL function, this paper is a review and distillation of these existing recommendations combined with the perspectives of four peak professional bodies to offer a practically focused resource to help MSLs interact, collaborate and exchange scientific information appropriately with external experts when out in the field.

Funder

Medical Affairs Professional Society

Australian Pharmaceutical medical and scientific Professionals Association

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference12 articles.

1. Sweiti H, et al. Physicians in the pharmaceutical industry: their roles, motivations, and perspectives. Drug Discovery Today. 2019;24(9):1865–70.

2. McGrail S. Impact of Medical Affairs on the Pharmaceutical Industry. Pharma News Intelligence. 2021. Available at: https://pharmanewsintel.com/news/impact-of-medical-affairs-on-the-pharmaceutical-industry. Accessed 6 May 2021.

3. Compliance Challenges within Medical Affairs, 2018. Available at: https://www.policymed.com/2014/06/compliance-challenges-within-medical-affairs.html.

4. Medical Science Liaison Society. Medical science liaison guidelines, 2018. Available at: https://www.themsls.org/msl-guidelines.

5. Japan Pharmaceutical Manufacturers Association (JPMA). Consensus Statement on Medical Science Liaison Activities, 2019. Available at: http://www.jpma.or.jp/english/policies_guidelines/pdf/msl-en_20190401.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3